Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05695365 · ClinicalTrials.gov registry record · NA
Feasibility of Resistance Exercise to Treat Major Depression Via Cerebrovascular Mechanisms
A NA study, sponsored by Iowa State University.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT05695365: Completed NA study, sponsored by Iowa State University.
NCT05695365 is a NA study that has completed, run by Iowa State University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05695365, a NA study, has completed, sponsored by Iowa State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This project is a single-arm pilot trial to investigate the feasibility, acceptability, and plausible efficacy of a 16-week resistance exercise training (RET) program for treatment of major depressive disorder.
Primary Outcome
Screening responses and timestamps will be used to assess the success of recruitment strategies and recruitment rate, calculated by taking the total number of participants recruited (i.e., completed screening survey) divided by the recruitment period duration. Enrollment rate will be calculated by taking the total number of participants enrolled divided by the recruitment period duration.
Interventions
- BEHAVIORAL Resistance Exercise Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2022-04-04 |
| Est. Completion | 2023-01-10 |
| Phase | NA |
What the finished NCT05695365 record still lists
NCT05695365 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Resistance Exercise Training is the first listed.
NCT05695365 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05695365 about?
NCT05695365 is a clinical study titled "Feasibility of Resistance Exercise to Treat Major Depression Via Cerebrovascular Mechanisms". This project is a single-arm pilot trial to investigate the feasibility, acceptability, and plausible efficacy of a 16-week resistance exercise training (RET) program for treatment of major depressive disorder.
What is the current status of trial NCT05695365?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2022-04-04. Estimated completion is 2023-01-10.
What interventions are being tested in trial NCT05695365?
The interventions under investigation include: Resistance Exercise Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05695365?
This trial is sponsored by Iowa State University, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05695365's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI